<DOC>
	<DOC>NCT01098097</DOC>
	<brief_summary>To study retreatment in patients who failed prior treatment with interferon alpha (pegylated or non-pegylated) with or without ribavirin in a real-life setting in an observational/noninterventional study.</brief_summary>
	<brief_title>Post Marketing Observational Study of Retreatment of Chronic Hepatitis C With Peginterferon Alpha and Ribavirin (Study P06011)</brief_title>
	<detailed_description>This is an observational/non interventional study to collect data on the patient characteristics of those seeking retreatment as well as safety and efficacy information during the first 12 weeks of retreatment.</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<criteria>Chronic hepatitis C of any genotype; Prior treatment with interferon alpha (pegylated or nonpegylated) with or without ribavirin did not result in a sustained virological response; Inclusion criteria listed on the approved label in each country; Willingness of the patient to participate and sign the Informed Consent Form. Patient exclusion from this observational/noninterventional study will be determined by the treating physician and will be based on the local label in each country.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>